Martin Edwards's Net Worth

$3.42 Million

Estimate Recalculated Nov 8, 2024 04:39PM EST

Who is Martin Edwards?

Martin Edwards has an estimated net worth of $3.42 Million. This is based on reported shares across multiple companies, which include Morphic Holding, Inc., REATA PHARMACEUTICALS INC, Verona Pharma plc, KalVista Pharmaceuticals, Inc., Inozyme Pharma, Inc., and CoLucid Pharmaceuticals, Inc..

SEC CIK

Martin Edwards's CIK is 0001640073

Past Insider Trading and Trends

2022 was Martin Edwards's most active year for acquiring shares with 9 total transactions. Martin Edwards's most active month to acquire stocks was the month of May. 2023 was Martin Edwards's most active year for disposing of shares, totalling 9 transactions. Martin Edwards's most active month to dispose stocks was the month of August. 2023 saw Martin Edwards paying a total of $293,130.14 for 164,768 shares, this is the most they've acquired in one year. In 2021 Martin Edwards cashed out on 25,712 shares for a total of $23,699.68, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Morphic Holding, Inc. (MORF) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 4
Form 4
∞
2.38K
$20.54
$48,803.04
2.38K
Nov 13
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 8
Form 4/A
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Dec 1
Form 3
—
0
—
—
0
No matching records found

REATA PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.12K
—
—
0
Sep 26
Form 4
+42.20%
1.81K
$93.61
$169,902.15
6.12K
Jun 7
Form 4
+7,189.83%
4.24K
$34.76
$147,451.92
4.3K
Jun 8
Form 4
∞
59
$27.32
$1,611.88
59
Jan 3
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Aug 3
Form 3
—
0
—
—
0
No matching records found

Verona Pharma plc (VRNA) Snapshot price: $26.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 29
Form 4
+30.38%
33.74K
$1.84
$61,973.03
144.8K
Nov 20
Form 4
—
0
—
—
0
Apr 28
Form 4
—
0
—
—
0
Apr 28
Form 4
—
0
—
—
0
Aug 9
Form 4
-9.77%
-12.02K
$0.84
-$10,096.55
111.06K
Scheduled
May 4
Form 4
-10.01%
-13.69K
$0.99
-$13,603.13
123.09K
Scheduled
Feb 1
Form 3
—
0
—
—
0
No matching records found

KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $12.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Jun 26
Form 3
—
0
—
—
0
No matching records found

Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jul 23
Form 3
—
0
—
—
0
No matching records found